Four-Month Rifapentine Regimens for Tuberculosis
- PMID: 35294822
- DOI: 10.1056/NEJMc2114483
Four-Month Rifapentine Regimens for Tuberculosis
Comment in
-
Four-Month Rifapentine Regimens for Tuberculosis. Reply.N Engl J Med. 2022 Mar 17;386(11):1095-1096. doi: 10.1056/NEJMc2114483. N Engl J Med. 2022. PMID: 35294823 No abstract available.
Comment on
-
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.N Engl J Med. 2021 May 6;384(18):1705-1718. doi: 10.1056/NEJMoa2033400. N Engl J Med. 2021. PMID: 33951360 Free PMC article. Clinical Trial.
Similar articles
-
Four-Month Rifapentine Regimens for Tuberculosis. Reply.N Engl J Med. 2022 Mar 17;386(11):1095-1096. doi: 10.1056/NEJMc2114483. N Engl J Med. 2022. PMID: 35294823 No abstract available.
-
Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?Am J Respir Crit Care Med. 2008 Nov 1;178(9):989-93. doi: 10.1164/rccm.200807-1029OC. Epub 2008 Aug 21. Am J Respir Crit Care Med. 2008. PMID: 18723432 Free PMC article.
-
Rifapentine: its role in the treatment of tuberculosis.Ann Pharmacother. 1999 Nov;33(11):1203-10. doi: 10.1345/aph.18450. Ann Pharmacother. 1999. PMID: 10573321 Review.
-
Rifapentine.Drugs. 1998 Oct;56(4):607-16; discussion 617. doi: 10.2165/00003495-199856040-00008. Drugs. 1998. PMID: 9806107 Review.
-
Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.Lancet. 1999 May 29;353(9167):1843-7. doi: 10.1016/s0140-6736(98)11467-8. Lancet. 1999. PMID: 10359410 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical